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a  b  s  t  r  a  c  t
Purpose: The treatment planning of bilateral breast irradiation (BBI) is a challenging task.
The overlapping of tangential fields is usually unavoidable without compromising the target
coverage. The purpose of this study was to investigate the technical feasibility and benefits
of  a single isocentre volumetric modulated arc therapy (VMAT) in BBI.
Methods and materials: Two women with bilateral breast cancer were included in this case
study. The first patient (Pat#1) underwent a bilateral breast-conserving surgery and sentinel
lymph node biopsy. The second patient (Pat#2) underwent a bilateral ablation and axillary
lymph node dissection. Planning target volumes (PTV) and organs at risk were delineated
on  CT images. VMAT plans were created with four (two for both sides, Pat#1) or two  (one
for  each breast, Pat#2) separate VMAT fields. Subsequently, traditional tangential field plans
were generated for each patient and the dosimetric parameters were compared.
Results: The treatment times of the patients with VMAT were less than 15 min with daily
CBCT imaging. When compared to the standard tangential field technique, the VMAT plans
improved the PTV dose coverage and dose homogeneity with improved sparing of lungs
and heart. With traditional field arrangement, the overlapping of the tangential fields was
inevitable without significantly compromising the target coverage, whereas with VMAT the
hotspots were avoided. The patients were treated with the VMAT technique and no acute
skin toxicity was observed with either of the patients.
Conclusions: A single isocentre VMAT technique has been implemented clinically for BBI.With  the VMAT techniques, the dose delivery was quick and the hotspots in the field over-lapping areas were avoid
compared with conventio
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.  Introduction
reast cancer is the leading cancer site in women world-
ide with an estimated 1.4 million new cases diagnosed
very year.1 Synchronous bilateral breast cancer (BBC) is very
ncommon, the latest estimate for the incidence being only
.1%.2 Although the number of cases of BBC is rare in one
reatment centre the overall BBC patient population grows
pproximately to 30,000 new cases a year worldwide. Com-
ared to unilateral breast cancer radiotherapy, the treatment
lanning and dose delivery of BBC is very complex and time
onsuming. One of the standard treatment techniques for BBC
s to use a tangential field configuration.3,4 With the traditional
angential field-arrangement either a significant amount of
eam overlap is needed or, alternatively, under-dosage of
ome parts of the PTV has to be accepted with some patient
roups. The drawbacks of the conventional tangential tech-
ique often also include inhomogeneous dose distribution
ith hotspots or inadequate coverage of the target structure,
specially with obese patients, or the inability to reduce the
igh dose volumes of the heart and ipsilateral lung. The dose
nhomogeneities have been correlated with radiation-induced
ermatitis, acute desquamation and late soft-tissue fibrosis
nd the quality of life of the treated patients has been reported
o decline by these physical symptoms.5–8
The use of a volumetric modulated arc therapy (VMAT) has
teadily increased in external beam radiotherapy. In VMAT
he radiation dose is delivered by continuously varying gantry
peed, field shape and dose rate. In the literature, there are
nly a few reports that have studied the modulated treat-
ent techniques for BBC. These studies are mainly treatment
lanning and dosimetric studies with an intensity modulated
adiotherapy (IMRT)9 or a VMAT  technique10 and the actual
adiotherapy treatments have been carried out with a conven-
ional technique. Intensity modulated proton11 and electron
rc12 treatment planning studies have also been investigated
or BBI. In our knowledge, the only reported case about BBC
atients treated with a modulated technique is a study of
endales et al.13 where they used Helical Tomotherapy for
omplex treatment volumes. Unfortunately, however, in that
articular study it was not specified how the treatment plans
ere accomplished and more  specific information about the
reatment planning for the bilateral breast cases were not
iven. In our knowledge, this is the first report to use a VMAT
echnique for bilateral breast irradiation (BBI) to enhance dose
istributions within the irradiated volume. In the present
tudy, we  report two cases of BBC patients treated with a single
socentric VMAT  technique.
.  Case  reports
.1.  Patient  histories  and  diagnoses
wo different patient cases are reported. The first case (Pat#1),
as a 67-year-old female with bilateral ductal breast car-
inoma. She underwent bilateral breast-conserving surgery
nd sentinel lymph node biopsy (right breast: T2N1M0 stage
IA, left breast: T1aN0M0 stage I). The second patient (Pat#2)therapy 2 0 ( 2 0 1 5 ) 398–402 399
was a 71-year-old female with bilateral multifocal lobular
breast carcinoma. She underwent bilateral ablation and axil-
lary lymph node dissection (right breast: T2N2M0 stage IIIA,
left breast: T2N2M0 stage IIIA). With both patients, chemother-
apy consisted of three cycles of docetaxel plus three cycles of
cyclophosphamide, epirubicin and fluorouracil (CEF).
2.2.  Imaging  and  treatment  planning
Both patients were imaged supine with a CT scanner (Toshiba
Aquilion LB, Toshiba Medical Systems Co., Tochigi, Japan) in
treatment position with a slice thickness of 2 mm.  Planning
target volumes (PTV) of the left and right breast were delin-
eated on the CT data according to the department guidelines.
With Pat#1 the PTV included the glandular breast tissue and
the lower part of the fossa axillae. With Pat#2 the chest wall
and the regional lymph node areas were included into the PTV.
Atlas-based auto-segmentation software (ABAS, Elekta AB,
Stockholm, Sweden) was used to delineate the critical struc-
tures which were verified by the user and manually corrected if
necessary. The critical structures delineated were both lungs,
heart, left anterior descending (LAD) coronary artery, thyroid
gland, shoulder joints and oesophagus.
The VMAT plans were generated on Monaco® treatment
planning system (TPS) (version 3.30.01, Elekta AB) for Elekta
Infinity linear accelerator with Agility MLC. The VMAT  plans
were created with four (two for both breast, Pat#1) or two
(one for each breast, Pat#2) separate VMAT  fields with an
energy of 6 MV. The field arrangements are shown in Fig. 1. The
plans were optimised simultaneously for all arcs with a sin-
gle isocentre located below sternum (Fig. 1). Treatment plans
were optimised with a maximum number of control points of
140, a minimum segment width of 1.0 cm and with high flu-
ence smoothing. An autoflash margin of 1.5 cm and surface
margin of 0.5 cm were used in the optimisation (e.g. the inner
margin from the skin surface that was excluded from the opti-
misation). A standard deviation of 1% was used in Monte Carlo
(MC) dose calculation with a dose grid of 3.0 mm.  The prescrip-
tion dose (50 Gy/25 fr) was normalised to the mean dose of the
PTV (excluding a 5 mm margin from the skin surface).
For comparative reasons, a traditional field-in-field (FinF)
tangential technique, which has become a standard technique
in breast cancer radiotherapy,14 was used to create a treatment
plan with the identical CT data and structure sets. In FinF,
planning subfields are created by manually moving the MLC
positions to enhance the dose homogeneity.15 The FinF plans
were generated in Oncentra® TPS (version 4.3.0.410, Elekta AB)
with an identical single isocentre. Dose distributions were cal-
culated with collapsed cone convolution (CCC) algorithm with
a dose grid of 3.0 mm.
2.3.  Treatment  verification
The calculated dose distributions of the VMAT plans were
verified by delivering the treatment plans to a MatriXX
ionisation chamber array with a MultiCube phantom (IBA,
Schwarzenbruck, Germany). The gantry angle corrections
were performed and the measured coronal planes were
compared against the calculated dose distributions (Fig. 2).
OmniProI’mRT (v1.7.0021, IBA) software was used to analyse
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Fig. 1 – The VMAT  field arrangements (the red arcs) and the axial dose distributions for the patients studied (A: Pat#1 and B:
 The Pat#2) with a dose colour wash ranging from 35 Gy to 60 Gy.
the results by using a gamma plot for 3% and 3 mm.  With both
treatment plans the gamma agreements were greater than
99.5%, which is shown in Fig. 2 for Pat#1.
2.4.  Treatment  delivery  with  image-guidance
With the reported patient cases a single daily cone-beam CT
(CBCT) imaging was performed to setup the patient (Fig. 3).
Low dose (tube current 20 mA,  exposure time 32 ms)  200◦ rota-
tion CBCT was performed on the Elekta XVI (Elekta, Crawley,
UK) with an aluminium bowtie filter to reduce panel saturation
effects16 and small field of view (FOV, reconstruction diam-
eter of 27 cm). Image  reconstruction and automatic image
registration was performed in XVI software (version 4.5.) by
using bone algorithm. The shifts to cranio-caudal, left–right
and anterior–posterior directions from the daily CBCT images
ranged between −0.7 and 0.7 cm (average 0.3 cm), 0.1–0.8 cm
(average 0.4 cm)  and −0.7 to 0.8 (average −0.2 cm), respectively.3.  Results  and  discussion
The PTV dose coverage was increased by using the VMAT
technique when compared to FinF technique, as the PTV
Fig. 2 – Calculated (A), measured (B) and the corresponding gamm
The gamma  agreement (±3%/±3 mm)  between the measured andsingle plan isocentre is marked with a red cross.
volume encompassed by the 95% isodose line (V95%; 47.5 Gy)
was increased on average from 84% to 98% (Fig. 4). When
compared to a standard tangential FinF technique, the VMAT
plans improved the dose homogeneity as the average V107%
(V53.5Gy) was decreased from 12.4% to 0.2%. The VMAT tech-
nique also improved the sparing of the surrounding critical
structures. The mean dose to both lungs was decreased on
average from 11.6 Gy to 10.1 Gy. The volume of the heart receiv-
ing doses greater than 25 Gy (V25Gy), which has been related to
radiation-associated cardiac diseases,17 was decreased from
6.5% to 4.2% when VMAT was compared against the FinF
technique. However, the mean dose to the heart was slightly
increased by using VMAT, from 5.7 Gy to 6.6 Gy, when com-
pared to the FinF technique. With traditional field arrange-
ment, the overlapping of the tangential fields was inevitable
as the maximum dose to a volume of 5 cm3 (D5cc) was on
average 67.0 Gy. With the VMAT technique, the hotspots in the
overlapping areas were avoided (the average D5cc = 52.7 Gy).
Overall, the VMAT treatment plans decreased the doses to
the lungs and heart and increased the dose homogeneity in
the treatment volume. The main drawback considering the
VMAT planning was a slight increase in the low dose volume.
However, the volume of the lungs covered by the dose of 5 Gy
a  evaluation of the two 2D-dose distributions (C) for Pat#1.
 the calculated dose was 99.9%.
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iven for Pat#1 and Pat#2 for axial (A, C) and coronal (B, D) d
V5Gy) was on average only 43%, while with the reported Heli-
al Tomotherapy treatment deliveries the respective volume
as 78%.13 Although the risk of second cancer among patients
reated with radiotherapy is small,18 it cannot be neglected.
he low dose volume has to be considered when selecting
he patients to be treated with a VMAT  bearing in mind the
ncreased possibility of second cancers, especially for patients
ith younger age. It should also be recognised that with the
ntroduced VMAT  dose delivery technique the treatment plan-
ing complexity is increased thus escalating the potential for
rror and thus increasing the importance of the quality assur-
nce processes.19
ig. 4 – Average cumulative dose volume histograms
DVHs) of the two patients for the two different techniques
tudied (FinF and VMAT).ions, respectively.
Patients were treated in 25 fractions to the total dose of
50 Gy with the VMAT technique. Total number of monitor
units (MU) with the VMAT technique was 1184 and 1585 MU
with Pat#1 and Pat#2, respectively, while with the tangential
technique the respective MUs were 455 and 913 MU. The over-
all treatment time with daily CBCT matching was less than
15 min  with both patients with an average beam-on time of
280 s. The cosmetic outcome was good and no breast oedema,
erythema or fibrosis were reported during routine follow-up.
Treatment planning for BBC is difficult and in most cases
the field overlapping cannot be avoided with traditional tan-
gential field arrangements. As a consequence, some patients
have been reported to develop fibrosis at the area of the
overlapping fields.3 Thus, to minimise damage to the skin,
the overlapping areas with large hotspots should be avoided.
On the other hand, the PTV area should receive the pre-
scription dose without cold spots to minimise the risk of
tumour recurrence. This paper describes the process of plan-
ning synchronous BBC radiotherapy with a single isocentre
VMAT  technique. The introduced technique decreases the
hotspots, increases the dose coverage and is easy to deliver.
The most important aspect with this technique is that the
major field overlapping problems existing with the tangential
field arrangements are avoided. As no treatment guidelines
exist for the BBC, our study highlights the possibility of a single
isocentre VMAT technique to enhance the dose distributions
in the treated area. The use of a single isocentre also simpli-
fies the treatment process decreasing the time spent on the
treatment machine.
Furthermore, to avoid long-term cardiac mortality, exten-













19. Malicki J. The importance of accurate treatment planning,402  reports of practical oncology an
field arrangements. This will, as a consequence, require the
acceptance of incomplete dose coverage of the PTV. With the
VMAT  technique, the high dose areas in the heart can be
avoided without compromising the PTV dose coverage.
4.  Conclusions
This case study represents feasibility of VMAT  technique in
the treatment of bilateral breast cancer. The introduced single
isocentric VMAT  technique is fast to deliver, it increases the
dose homogeneity of the target volume and avoids the field
overlapping problems. The delivered VMAT  treatments were
well tolerated without treatment related toxicities after the
treatment courses.




 e  f  e  r  e  n  c  e  s
1. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of
cancer incidence and mortality rates and trends. Cancer
Epidemiol Biomarkers Prev 2010;19:1893–907.
2. Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast
cancer: analysis of incidence, outcome, survival and disease
characteristics. Breast Cancer Res Treat 2011;126:131–40.
3. Yamauchi C, Mitsumori M, Nagata Y, et al. Bilateral
breast-conserving therapy for bilateral breast cancer: results
and consideration of radiation technique. Breast Cancer
2005;12:135–9.
4. Fung MC, Schultz DJ, Solin LJ. Early-stage bilateral breast
cancer treated with breast-conserving surgery and definitive
irradiation: the University of Pennsylvania experience. Int J
Radiat Oncol Biol Phys 1997;38:959–67.
5. Back M, Guerrieri M, Wratten C, Steigler A. Impact of
radiation therapy on acute toxicity in breast conservation
therapy for early breast cancer. Clin Oncol (R Coll Radiol)
2004;16:12–6.
6. Fisher J, Scott C, Stevens R, et al. Randomized phase III study
comparing Best Supportive Care to Biafine as a prophylactic
agent for radiation-induced skin toxicity for womeniotherapy 2 0 ( 2 0 1 5 ) 398–402
undergoing breast irradiation: Radiation Therapy Oncology
Group (RTOG) 97-13. Int J Radiat Oncol Biol Phys
2000;48:1307–10.
7. Mukesh MB, Harris E, Collette S, et al. Normal tissue
complication probability (NTCP) parameters for breast
fibrosis: pooled results from two randomised trials. Radiother
Oncol 2013;108:293–8.
8. Poortmans P, Marsiglia H, De Las Heras M, Algara M. Clinical
and  technological transition in breast cancer. Rep Pract Oncol
Radiother 2013;18(6):345–52.
9. Lee TF, Ting HM, Chao PJ, et al. Dosimetric advantages of
generalised equivalent uniform dose-based optimisation on
dose-volume objectives in intensity-modulated radiotherapy
planning for bilateral breast cancer. Br J Radiol
2012;85:1499–506.
0. Nicolini G, Clivio A, Fogliata A, Vanetti E, Cozzi L.
Simultaneous integrated boost radiotherapy for bilateral
breast: a treatment planning and dosimetric comparison for
volumetric modulated arc and fixed field intensity
modulated therapy. Radiat Oncol 2009;24(4):27.
1. Jimenez RB, Goma C, Nyamwanda J, et al. Intensity
modulated proton therapy for postmastectomy radiation of
bilateral implant reconstructed breasts: a treatment planning
study. Radiother Oncol 2013;107:213–7.
2. Sharma PK, Jamema SV, Kaushik K, et al. Electron arc therapy
for bilateral chest wall irradiation: treatment planning and
dosimetric study. Clin Oncol (R Coll Radiol) 2011;23:216–22.
3. Cendales R, Schiappacasse L, Schnitman F, García G, Marsiglia
H.  Helical tomotherapy in patients with breast cancer and
complex treatment volumes. Clin Transl Oncol 2011;13:268–74.
4. Algara M, Arenas M, De Las Peñas Eloisa Bayo D, et al.
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